1
|
Jomard A, Chavez-Talavera O, Tailleux A, Ruschitzka F, Von Eckardstein A, Staels B, Osto E. The role of BA AS signaling molecules and novel therapeutic targets to protect endothelial metabolism and function against obesity. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
2
|
Jomard A, Chavez-Talavera O, Doytcheva P, Tailleux A, Wolfrum C, Lutz T, Ruschitzka F, von Eckardstein A, Staels B, Osto E. Best Poster Award - Second Prize: Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target. Eur Cardiol 2020; 15:e25. [PMID: 32612685 PMCID: PMC7312619 DOI: 10.15420/ecr.2020.15.1.po2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Affiliation(s)
| | | | | | | | | | | | | | | | | | - E Osto
- Schlieren-Zurich, Switzerland
| |
Collapse
|
3
|
Jomard A, Chavez-Talavera O, Tailleux A, Bueter M, Taheri A, Wolfrum C, Lutz TA, Von Eckardstein A, Ruschitzka F, Staels B, Osto E. P729The functional relevance of bile acids in the improvement of HDL-mediated endothelial protection after bariatric surgery. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Roux-en-Y gastric bypass (RYGB) reduces cardiovascular mortality. We showed that high density lipoproteins (HDL)-mediated vasoprotection is improved early after RYGB. Circulating BAs increase upon RYGB and contribute to the weight-loss independent metabolic improvements after surgery. Bile acids (BA) are signaling molecules increasingly recognized as regulators of cardiometabolic homeostasis. BAs circulate in the blood either free or bound to albumin and HDL. The signaling role of HDL-bound BAs (HDL-BAs) is unknown. Indeed, HDL may facilitate BA delivery directly to endothelial cells where BA may synergize with HDL to promote vasoprotection.
Purpose
We studied whether RYGB changes the composition of HDL-BA and whether HDL functional properties may be modulated by specific BA bound to HDL.
Methods
HDL were isolated by ultracentrifugation from 29 morbidly obese patients before and 1 year after RYGB. The HDL-BA composition was determined by liquid chromatography-mass spectrometry (LC/MS-MS) and HDL vasoprotective properties were evaluated ex-vivo in human aortic endothelial cells (HAEC). The size and abundance of HDL particles were determined by NMR spectroscopy in plasma.
Results
The increase in total BA concentrations observed in plasma 1 year after RYGB also translated into higher concentrations (up to 25%) of BA bound to HDL. Moreover, obesity-induced HDL dysfunction was reversed after surgery, as shown by improved HDL-mediated endothelial NO production, anti-apoptotic effects and cholesterol efflux capacity. The size function analyses showed a post-operative shift towards larger HDL. After RYGB there was a remodeling of BA bound to HDL, which are either agonists of the endothelial nuclear farnesoid X receptor (FXR), e.g. chenodeoxy-CA (CDCA), cholic acid (CA) or for the membrane TGR5 receptor, e.g. deoxy-CA (DCA). The composition-function analysis revealed that among all BA subclasses, the specific enrichment in CA and in CDCA bound to HDL correlated with an improved endothelial anti-apoptotic capacity of HDL (R −0.52, p=0.006 for CA-HDL and R −0.35, p=0.07 for CDCA-HDL). Further, the exogenous loading of CA onto healthy native HDL isolated from human serum significantly enhanced their endothelial anti-apoptotic function. In the case of obese, dysfunctional, pro-apoptotic HDL, exogenous CA loading was able to restore HDL anti-apoptotic function.
Conclusion
Exogenous loading of CA restored HDL anti-apoptotic function of HDL from obese patients mimicking the beneficial remodeling of BA bound to HDL observed after RYGB. These results suggest a crucial interaction between endothelial cells and BA in the improvement of HDL's vasoprotective properties.
Acknowledgement/Funding
Swiss national Science Foundation Ambizione and PRIMA grant to EO
Collapse
Affiliation(s)
- A Jomard
- Swiss Federal Institute of Technology Zurich (ETH Zurich), Laboratory of Translational Nutrition Biology, Zurich, Switzerland
| | | | - A Tailleux
- Institute Pasteur of Lille, Lille, France
| | - M Bueter
- University Hospital Zurich, Zurich, Switzerland
| | - A Taheri
- University of Zurich, veterinary physiology, Zurich, Switzerland
| | - C Wolfrum
- Swiss Federal Institute of Technology Zurich (ETH Zurich), Laboratory of Translational Nutrition Biology, Zurich, Switzerland
| | - T A Lutz
- University of Zurich, veterinary physiology, Zurich, Switzerland
| | | | - F Ruschitzka
- University Hospital Zurich, Univeristy Heart Center, Zurich, Switzerland
| | - B Staels
- Institute Pasteur of Lille, Lille, France
| | - E Osto
- University Hospital Zurich, Univeristy Heart Center, Zurich, Switzerland
| |
Collapse
|
4
|
Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, Dreno B, Gamboa B, Jomard A, Luzy AP, Mauvais P, Mounier C, Pascau J, Pelisson I, Portal T, Rivier M, Rossio P, Thoreau E, Vial E, Voegel JJ. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene. Br J Dermatol 2018; 179:442-456. [PMID: 29974453 DOI: 10.1111/bjd.16719] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/07/2018] [Indexed: 12/28/2022]
Abstract
BACKGROUND First- and third-generation retinoids are the main treatment for acne. Even though efficacious, they lack full selectivity for retinoic acid receptor (RAR) γ, expressed in the epidermis and infundibulum. OBJECTIVES To characterize the in vitro metabolism and the pharmacology of the novel retinoid trifarotene. MATERIALS AND METHODS In vitro assays determined efficacy, potency and selectivity on RARs, as well as the activity on the expression of retinoid target genes in human keratinocytes and ex vivo cultured skin. In vivo studies investigated topical comedolytic, anti-inflammatory and depigmenting properties. The trifarotene-induced gene expression profile was investigated in nonlesional skin of patients with acne and compared with ex vivo and in vivo models. Finally, the metabolic stability in human keratinocytes and hepatic microsomes was established. RESULTS Trifarotene is a selective RARγ agonist with > 20-fold selectivity over RARα and RARβ. Trifarotene is active and stable in keratinocytes but rapidly metabolized by human hepatic microsomes, predicting improved safety. In vivo, trifarotene 0·01% applied topically is highly comedolytic and has anti-inflammatory and antipigmenting properties. Gene expression studies indicated potent activation of known retinoid-modulated processes (epidermal differentiation, proliferation, stress response, retinoic acid metabolism) and novel pathways (proteolysis, transport/skin hydration, cell adhesion) in ex vivo and in vivo models, as well as in human skin after 4 weeks of topical application of trifarotene 0·005% cream. CONCLUSIONS Based on its RARγ selectivity, rapid degradation in human hepatic microsomes and pharmacological properties including potent modulation of epidermal processes, topical treatment with trifarotene could result in good efficacy and may present a favourable safety profile in acne and ichthyotic disorders.
Collapse
Affiliation(s)
- J Aubert
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - D Piwnica
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - B Bertino
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - S Blanchet-Réthoré
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - I Carlavan
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - S Déret
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - B Dreno
- Department of Dermatology, Nantes University Hospital, Nantes, France
- CIC, Inserm U892-CNRS 6299, Nantes, France
| | - B Gamboa
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - A Jomard
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - A P Luzy
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - P Mauvais
- Pharma & Life Sciences Xpert, Antibes, France
| | - C Mounier
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - J Pascau
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - I Pelisson
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - T Portal
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - M Rivier
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - P Rossio
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - E Thoreau
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - E Vial
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| | - J J Voegel
- Research Department, Galderma R&D, Les Templiers, 2400 Route des Colles, 06410, Biot, France
| |
Collapse
|
5
|
Jomard A, Doytcheva P, Deuel J, Luscher T, Wolfrum C, Lutz T, Osto E. P533The functional relevance of HDL structure and composition in the improvement of cholesterol efflux capacity after Roux-en-Y gastric bypass. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy060.389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Jomard
- Swiss Federal Institute of Technology Zurich (ETH Zurich), Laboratory of Translational Nutrition Biology, Zurich, Switzerland
| | - P Doytcheva
- University of Zurich, Center for Molecular Cardiology, Zurich, Switzerland
| | - J Deuel
- University Hospital Zurich, Internal medicine, Zurich, Switzerland
| | - T Luscher
- University of Zurich, Center for Molecular Cardiology, Zurich, Switzerland
| | - C Wolfrum
- Swiss Federal Institute of Technology Zurich (ETH Zurich), Laboratory of Translational Nutrition Biology, Zurich, Switzerland
| | - T Lutz
- University of Zurich, Center for Molecular Cardiology, Zurich, Switzerland
| | - E Osto
- University of Zurich, Center for Molecular Cardiology, Zurich, Switzerland
| |
Collapse
|
6
|
Ventre E, Rozières A, Lenief V, Albert F, Rossio P, Laoubi L, Dombrowicz D, Staels B, Ulmann L, Julia V, Vial E, Jomard A, Hacini-Rachinel F, Nicolas JF, Vocanson M. Topical ivermectin improves allergic skin inflammation. Allergy 2017; 72:1212-1221. [PMID: 28052336 DOI: 10.1111/all.13118] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/22/2016] [Indexed: 12/23/2022]
Abstract
BACKGROUND Ivermectin (IVM) is widely used in both human and veterinary medicine to treat parasitic infections. Recent reports have suggested that IVM could also have anti-inflammatory properties. METHODS Here, we investigated the activity of IVM in a murine model of atopic dermatitis (AD) induced by repeated exposure to the allergen Dermatophagoides farinae, and in standard cellular immunological assays. RESULTS Our results show that topical IVM improved allergic skin inflammation by reducing the priming and activation of allergen-specific T cells, as well as the production of inflammatory cytokines. While IVM had no major impact on the functions of dendritic cells in vivo and in vitro, IVM impaired T-cell activation, proliferation, and cytokine production following polyclonal and antigen-specific stimulation. CONCLUSION Altogether, our results show that IVM is endowed with topical anti-inflammatory properties that could have important applications for the treatment of T-cell-mediated skin inflammatory diseases.
Collapse
Affiliation(s)
- E. Ventre
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - A. Rozières
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - V. Lenief
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - F. Albert
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - P. Rossio
- Nestlé Skin Health R&D; Sophia-Antipolis; Biot France
| | - L. Laoubi
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - D. Dombrowicz
- Université de Lille; INSERM; CHU de Lille; European Genomic Institute of Diabetes; Institut Pasteur de Lille; U1011-récepteurs nucléaires maladies cardiovasculaires et diabète; Lille France
| | - B. Staels
- Université de Lille; INSERM; CHU de Lille; European Genomic Institute of Diabetes; Institut Pasteur de Lille; U1011-récepteurs nucléaires maladies cardiovasculaires et diabète; Lille France
| | - L. Ulmann
- Institut de Génomique Fonctionnelle; CNRS; INSERM; Université de Montpellier; Montpellier France
| | - V. Julia
- Nestlé Skin Health R&D; Sophia-Antipolis; Biot France
| | - E. Vial
- Nestlé Skin Health R&D; Sophia-Antipolis; Biot France
| | - A. Jomard
- Nestlé Skin Health R&D; Sophia-Antipolis; Biot France
| | | | - J.-F. Nicolas
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| | - M. Vocanson
- CIRI; International Center for Infectiology Research; Université de Lyon; INSERM, U1111; Ecole Normale Supérieure de Lyon; Centre International de Recherche en Infectiologie; Université Lyon 1; CNRS; UMR 5308; Lyon France
| |
Collapse
|
7
|
Alamshah A, Spreckley E, Norton M, Kinsey-Jones JS, Amin A, Ramgulam A, Cao Y, Johnson R, Saleh K, Akalestou E, Malik Z, Gonzalez-Abuin N, Jomard A, Amarsi R, Moolla A, Sargent PR, Gray GW, Bloom SR, Murphy KG. l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents. Int J Obes (Lond) 2017; 41:1693-1701. [PMID: 28792489 PMCID: PMC5678004 DOI: 10.1038/ijo.2017.164] [Citation(s) in RCA: 82] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2016] [Revised: 05/26/2017] [Accepted: 06/21/2017] [Indexed: 12/11/2022]
Abstract
OBJECTIVE High-protein diets (HPDs) are associated with greater satiety and weight loss than diets rich in other macronutrients. The exact mechanisms by which HPDs exert their effects are unclear. However, evidence suggests that the sensing of amino acids produced as a result of protein digestion may have a role in appetite regulation and satiety. We investigated the effects of l-phenylalanine (L-Phe) on food intake and glucose homeostasis in rodents. METHODS We investigated the effects of the aromatic amino-acid and calcium-sensing receptor (CaSR) agonist l-phenylalanine (L-Phe) on food intake and the release of the gastrointestinal (GI) hormones peptide YY (PYY), glucagon-like peptide-1 (GLP-1) and ghrelin in rodents, and the role of the CaSR in mediating these effects in vitro and in vivo. We also examined the effect of oral l-Phe administration on glucose tolerance in rats. RESULTS Oral administration of l-Phe acutely reduced food intake in rats and mice, and chronically reduced food intake and body weight in diet-induced obese mice. Ileal l-Phe also reduced food intake in rats. l-Phe stimulated GLP-1 and PYY release, and reduced plasma ghrelin, and also stimulated insulin release and improved glucose tolerance in rats. Pharmacological blockade of the CaSR attenuated the anorectic effect of intra-ileal l-Phe in rats, and l-Phe-induced GLP-1 release from STC-1 and primary L cells was attenuated by CaSR blockade. CONCLUSIONS l-Phe reduced food intake, stimulated GLP-1 and PYY release, and reduced plasma ghrelin in rodents. Our data provide evidence that the anorectic effects of l-Phe are mediated via the CaSR, and suggest that l-Phe and the CaSR system in the GI tract may have therapeutic utility in the treatment of obesity and diabetes. Further work is required to determine the physiological role of the CaSR in protein sensing in the gut, and the role of this system in humans.
Collapse
Affiliation(s)
- A Alamshah
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - E Spreckley
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - M Norton
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - J S Kinsey-Jones
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - A Amin
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - A Ramgulam
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - Y Cao
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - R Johnson
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - K Saleh
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - E Akalestou
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - Z Malik
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - N Gonzalez-Abuin
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - A Jomard
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - R Amarsi
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - A Moolla
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.,Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
| | | | | | - S R Bloom
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| | - K G Murphy
- Section of Endocrinology and Investigative Medicine, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK
| |
Collapse
|
8
|
Del Bino S, Vioux C, Rossio-Pasquier P, Jomard A, Demarchez M, Asselineau D, Bernerd F. Ultraviolet B induces hyperproliferation and modification of epidermal differentiation in normal human skin grafted on to nude mice. Br J Dermatol 2004; 150:658-67. [PMID: 15099361 DOI: 10.1111/j.0007-0963.2004.05886.x] [Citation(s) in RCA: 58] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND For ethical and technical reasons, the in vivo biological effects of ultraviolet (UV) radiation on skin are difficult to study in human volunteers. The use of human skin grafted on to nude mice may circumvent this difficulty. OBJECTIVES To investigate the effects of a single moderate UVB exposure on human skin grafted on to nude mice. METHODS Modifications of epidermal differentiation markers and patterns of keratin expression were assessed from 24 h to 14 days after a physiological UVB irradiation characterized by the induction of sunburn cells. RESULTS During the first 48 h postexposure, involucrin, loricrin, transglutaminase type I, filaggrin and keratin K2e expression were altered together with the formation of abnormal horny layers. Constitutive keratin K14 was increased while keratin K10 expression was delayed. Newly synthesized keratins K6, K16, K17 and K19 were induced in parallel with an increase in the epidermal proliferation rate. A progressive normalization of both keratinocyte proliferation and differentiation took place during the following days, reaching completion within 2 weeks. CONCLUSIONS Exposure of human skin to a UVB dose corresponding to a mild sunburn reaction induces epidermal hyperproliferation and alterations of several constitutive differentiation markers, as well as a drastic modification in the pattern of epidermal keratins. Although these modifications were shown to be progressively reversed in a single exposure model, the data also suggest that subsequent UV exposures occurring during the recovery period may lead to potentially deleterious long-term consequences, such as photoageing and photocarcinogenesis. Grafted human skin appeared to be an attractive and promising model for investigating the biological consequences of UVB radiation in vivo.
Collapse
Affiliation(s)
- S Del Bino
- L'Oréal Research, Clichy, France, and Galderma R&D, 635 route des Lucioles, BP87, 06902 Sophia Antipolis, France.
| | | | | | | | | | | | | |
Collapse
|
9
|
Abstract
Androgens have profound effects on the physiology of the sebaceous gland. Using the hamster ear sebaceous gland model, we performed a detailed kinetic study to clarify the mechanism of androgen action on sebaceous gland function. We demonstrated that the growth of sebaceous glands observed after androgen treatment was due to both an increase in sebocyte proliferation and a parallel induction of sebocyte terminal differentiation, as evidenced by the induction of the synthesis of specific sebaceous lipids such as cholesterol esters, triglycerides, and squalene. Accordingly, the effect of androgen treatment on the mRNA expression of several key enzymes involved in the synthesis of sebaceous lipids has been studied using semi-quantitative RT-PCR. Up-regulation by androgens of mRNA expression of HMG coenzyme A synthase and reductase, acetyl coenzyme A carboxylase (ACC), glycerol 3-phosphate acyl transferase (GPAT), and FAR-17c (stearoyl coenzyme A desaturase homologous), was demonstrated. Because sterol-response element(s) (SREs) are known to be present in the promoters of these genes, we analyzed the expression by RT-PCR and the activation of the transcription factor sterol regulatory element binding protein (SREBP) using immunoblotting experiments. Our results showed that SREBP-1 was up-regulated and rapidly activated after androgen treatment. Altogether, these results demonstrate for the first time that in sebaceous glands, in vivo, androgen regulates the synthesis of sebum lipids through the SREBP pathway.
Collapse
Affiliation(s)
- C Rosignoli
- GALDERMA R & D, Sophia Antipolis cedex, Valbonne, France; INSERM U439 Pathologie Moléculaire des Récepteurs Nucléaires, Montpellier, France
| | | | | | | |
Collapse
|
10
|
Rossio-Pasquier P, Casanova D, Jomard A, Démarchez M. Wound healing of human skin transplanted onto the nude mouse after a superficial excisional injury: human dermal reconstruction is achieved in several steps by two different fibroblast subpopulations. Arch Dermatol Res 1999; 291:591-9. [PMID: 10638332 DOI: 10.1007/s004030050460] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
It has been established that human skin grafted onto the nude mouse is able to regenerate after being subjected to a full-thickness wound. In the present work, we sought to determine the cells involved in the connective tissue repair process following superficial wounding. Two months after transplantation, superficial wounds were made at the center of the graft using mechanical dermabrasion. At various times thereafter, ranging from 2 days to 6 weeks, healing grafts were harvested and processed for immunohistological study with species-specific and cross-reacting antibodies directed against human or mouse antigens. The grafted human skin regenerated according to the following series of events. First, the human dermis underneath the scab became devoid of human fibroblasts while the surrounding human dermis preserved its own characteristics. The TUNEL reaction on earlyphase healing wounds indicated that apoptosis occurred steadily within this area and could be the mechanism by which cells disappeared. Moreover, cell death was reduced when the wound was covered with an occlusive dressing. The human dermis beneath the wound was then invaded by mouse cells which deposited type I collagen on the human extracellular matrix and produced mouse granulation tissue at the surface above it. Human keratinocytes migrated over the mouse granulation tissue to reconstruct the epidermis. Eventually, the mouse granulation tissue was progressively invaded by human fibroblasts, which formed a human neodermis. The overall process appeared to depend upon several successive epithelial-mesenchymal interactions, which were not species-specific. This suggests that myofibroblasts arise from a specific subpopulation of fibroblasts, probably located at the interface between the dermis and adipose tissue, and that the granulation tissue is eventually remodeled by another population of fibroblasts present in the human dermis.
Collapse
|
11
|
Abstract
Adapalene, a synthetic retinoid, is a new drug proposed for the treatment of acne patients. Studies on the in vitro and in vivo pharmacology of adapalene have shown that it is very active on cell and tissue proliferation and differentiation. Furthermore, adapalene has anti-inflammatory potential as determined by its anti-AP1 activity. Adapalene interacts selectively with the nuclear receptors RAR beta and RAR gamma, and its activity on proliferation and differentiation can be blocked by a RAR beta-gamma antagonist. Because RAR beta is not expressed in human keratinocytes, the effect of adapalene on the major cell type of the epidermis is certainly mediated by its interaction with RAR gamma. The unique pharmacological properties of adapalene may explain why, when compared to tretinoin, it has an improved therapeutic ratio due to its better tolerance.
Collapse
Affiliation(s)
- S Michel
- Galderma R & D, Valbonne, France
| | | | | |
Collapse
|
12
|
Bouclier M, Jomard A, Kail N, Shroot B, Hensby C. Induction of ornithine decarboxylase activity in hairless rat epidermis as a pharmacological model: validation of the animal model. Lab Anim 1987; 21:233-40. [PMID: 3626471 DOI: 10.1258/002367787781268855] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
We use a mutant hairless Sprague Dawley rat to evaluate the capacity of retinoids to inhibit the epidermal ornithine decarboxylase activity induced by sellotape stripping. In order to minimize the variability introduced by the animals in our model we decided to validate the hairless rats used. A number of animal parameters were examined using a single lot of 50 males and 50 females aged from 4 to 11 weeks and acclimatized to laboratory conditions. The body weight growth curves were established. Nude animals present two periods of hair growth, the first at 6-7 weeks and the second at about 10-11 weeks. Hair development is more pronounced in males. No histological change was observed in the stratum corneum but an increase in epidermal thickness was noted in males aged 9 weeks. Removal of the stratum corneum by sellotape stripping was more effective and reproducible in the females, as determined histologically. Sellotape-stripping induction of ornithine decarboxylase in the epidermis was higher in rats aged 5-6 weeks and reached a plateau in animals aged 6-12 weeks. Individual variations obtained were lower in females (about 5%-10% in females and 10%-20% in males). The present research suggests that female rats aged about 8 weeks provide maximum reproducibility of response and ease of use.
Collapse
|